Oxygenta Pharmaceutical Limited (BOM:524636)
India · Delayed Price · Currency is INR 49.38
-1.65 (-3.23%)
At close: May 26, 2026
Oxygenta Pharmaceutical Market Cap
Oxygenta Pharmaceutical has a market cap or net worth of 1.95 billion as of May 27, 2026. Its market cap has decreased by -37.26% in one year.
Market Cap
1.95B
Enterprise Value
3.02B
Revenue
1.13B
Ranking
n/a
PE Ratio
n/a
Stock Price
49.38
Market Cap Chart
Since June 4, 1997, Oxygenta Pharmaceutical's market cap has increased from 7.22M to 1.95B, an increase of 26,907.26%. That is a compound annual growth rate of 21.30%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 26, 2026 | 1.83B | -11.49% |
| Dec 31, 2025 | 2.06B | -36.22% |
| Dec 31, 2024 | 3.23B | 210.06% |
| Dec 29, 2023 | 1.04B | 159.15% |
| Dec 30, 2022 | 402.61M | 2.53% |
| Dec 31, 2021 | 392.67M | 307.32% |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Ambalal Sarabhai Enterprises | 2.53B |
| Everest Organics | 2.43B |
| Astonea Labs | 2.39B |
| BDH Industries | 2.07B |
| Speciality Medicines | 1.84B |
| Sanjivani Paranteral | 1.78B |
| Parnax Lab | 1.70B |
| Coral Laboratories | 1.66B |